Atherosclerosis Plaque Reduction by Lycopene Is Mediated by Increased Energy Expenditure through AMPK and PPARα in ApoE KO Mice Fed with a High Fat Diet.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
12 07 2022
Historique:
received: 28 04 2022
revised: 06 07 2022
accepted: 08 07 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 29 7 2022
Statut: epublish

Résumé

Lycopene is a carotenoid found in tomatoes that has potent antioxidant activity. The Mediterranean diet is particularly rich in lycopene, which has well-known beneficial effects on cardiovascular health. We tested the effects of lycopene extract in a group of 20 ApoE knockout mice, fed with a high fat western diet for 14 weeks. Starting from week 3 and up to week 14, the mice were randomly divided into two groups that received lycopene (n = 10) by oral suspension every day at the human equivalent dose of 60 mg/day (0.246 mg/mouse/day), or the vehicle solution (n = 10). The lycopene administration reduced triglycerides and cholesterol blood levels starting from week 6 and continuing through to the end of the experiment (p < 0.001). This reduction was mediated by an enhanced liver expression of PPAR-α and AMPK-α and reduced SREBP levels (p < 0.0001). As a histological red-out, the extent of atherosclerotic plaques and the intima−media thickness in the aorta were significantly reduced by lycopene. In this context, lycopene augmented the Nrf-2 positivity staining in the endothelium, thereby confirming that its antioxidant activity was mediated by this nuclear factor. The positive results obtained in this pre-clinical model further support the use of lycopene extracts to reduce atherosclerosis.

Identifiants

pubmed: 35883529
pii: biom12070973
doi: 10.3390/biom12070973
pmc: PMC9313394
pii:
doi:

Substances chimiques

Antioxidants 0
Apolipoproteins E 0
PPAR alpha 0
AMP-Activated Protein Kinases EC 2.7.11.31
Lycopene SB0N2N0WV6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Cell Metab. 2009 Apr;9(4):327-38
pubmed: 19356714
J Nutr. 2011 May;141(5):863-9
pubmed: 21411607
Methods Mol Biol. 2003;209:293-309
pubmed: 12357958
Maturitas. 2011 Apr;68(4):299-310
pubmed: 21163596
Mol Cell. 2007 Oct 12;28(1):91-106
pubmed: 17936707
Curr Opin Lipidol. 2015 Oct;26(5):357-61
pubmed: 26218415
Biochem Biophys Res Commun. 1997 Apr 28;233(3):658-62
pubmed: 9168909
Am Heart J. 2002 Mar;143(3):467-74
pubmed: 11868053
Sci China Life Sci. 2018 Oct;61(10):1212-1221
pubmed: 29656339
J Biol Regul Homeost Agents. 2011 Jul-Sep;25(3):435-41
pubmed: 22023768
Proc Nutr Soc. 2017 May;76(2):122-129
pubmed: 27609297
Biomolecules. 2018 Aug 23;8(3):
pubmed: 30142970
Crit Rev Food Sci Nutr. 2016 Aug 17;56(11):1868-79
pubmed: 25675359
Biochim Biophys Acta. 2010 Aug;1804(8):1652-7
pubmed: 19962456
Clin Sci (Lond). 2018 Jun 21;132(12):1243-1252
pubmed: 29930142
Biomedicines. 2020 Jun 17;8(6):
pubmed: 32560286
Curr Pharm Des. 2017;23(8):1216-1227
pubmed: 28034355
Clin Exp Pharmacol Physiol. 2015 Jun;42(6):632-9
pubmed: 25932745
Curr Opin Lipidol. 2009 Apr;20(2):98-105
pubmed: 19276888
Front Pharmacol. 2018 May 23;9:521
pubmed: 29875663
Proc Natl Acad Sci U S A. 2008 Jul 15;105(28):9793-8
pubmed: 18599449
Front Pharmacol. 2018 May 29;9:506
pubmed: 29896101
Oxid Med Cell Longev. 2017;2017:6341671
pubmed: 29379585
Eur J Pharmacol. 2008 May 31;586(1-3):275-82
pubmed: 18439578
Br J Pharmacol. 2018 Feb;175(4):644-655
pubmed: 29178246
Eur J Nutr. 2003 Aug;42(4):201-6
pubmed: 12923651
PLoS One. 2012;7(1):e30808
pubmed: 22295112
Exp Biol Med (Maywood). 2002 Nov;227(10):908-13
pubmed: 12424333
Molecules. 2018 May 14;23(5):
pubmed: 29757945
Arch Cardiovasc Dis. 2016 Dec;109(12):708-715
pubmed: 27595467
J Agric Food Chem. 2021 Sep 8;69(35):10114-10120
pubmed: 34428895
Free Radic Biol Med. 2011 Sep 1;51(5):978-92
pubmed: 21627987
Nutrition. 2008 Oct;24(10):1030-8
pubmed: 18585898
Exp Biol Med (Maywood). 2002 Nov;227(10):920-3
pubmed: 12424335
Nutrition. 2006 Mar;22(3):259-65
pubmed: 16413753
Br J Pharmacol. 2010 Aug;160(7):1573-6
pubmed: 20649560
Cardiovasc Drugs Ther. 2015 Aug;29(4):319-27
pubmed: 26006701
Neuromolecular Med. 2015 Jun;17(2):192-201
pubmed: 25893744
PLoS One. 2013 May 21;8(5):e64107
pubmed: 23700460
Cureus. 2020 Jul 23;12(7):e9349
pubmed: 32742886
Nutrients. 2020 Apr 26;12(5):
pubmed: 32357526
J Biol Chem. 2008 Jul 18;283(29):20015-26
pubmed: 18482975

Auteurs

Federica Mannino (F)

Department of Clinical and Experimental Medicine, University of Messina, Via C. Valeria, 98125 Messina, Italy.

Giovanni Pallio (G)

Department of Clinical and Experimental Medicine, University of Messina, Via C. Valeria, 98125 Messina, Italy.

Domenica Altavilla (D)

Department of Biomedical, Dental, Morphological and Functional Imaging Sciences, University of Messina, Via C. Valeria, 98125 Messina, Italy.
SunNutraPharma s.r.l., Spin-Off Company of University of Messina, Via C. Valeria, 98125 Messina, Italy.

Francesco Squadrito (F)

Department of Clinical and Experimental Medicine, University of Messina, Via C. Valeria, 98125 Messina, Italy.
SunNutraPharma s.r.l., Spin-Off Company of University of Messina, Via C. Valeria, 98125 Messina, Italy.

Giovanna Vermiglio (G)

Department of Biomedical, Dental, Morphological and Functional Imaging Sciences, University of Messina, Via C. Valeria, 98125 Messina, Italy.

Alessandra Bitto (A)

Department of Clinical and Experimental Medicine, University of Messina, Via C. Valeria, 98125 Messina, Italy.
SunNutraPharma s.r.l., Spin-Off Company of University of Messina, Via C. Valeria, 98125 Messina, Italy.

Natasha Irrera (N)

Department of Clinical and Experimental Medicine, University of Messina, Via C. Valeria, 98125 Messina, Italy.
SunNutraPharma s.r.l., Spin-Off Company of University of Messina, Via C. Valeria, 98125 Messina, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH